AbstractBackgroundFew studies have incorporated echocardiography and laboratory data to predict clinical outcomes in heart failure with preserved ejection fraction (HFpEF).ObjectivesThis study aime…
Key Points. The incidence of primary refractory disease has decreased with modern therapy, but it is a significant risk factor for shorter survival.Salvage auto
Sleep information – Importance of sleep, sleep benefits, sleep stages, sleep hygiene, sleep depreciation, sleep problems/disorders, and sleep aids.
Pennsylvania’s #1 online therapy & counseling centers. Click here for help with relationships and all other mental health needs.
Dr. Anne Morse provides a run-down of the important trends, and therapeutic innovations to occur in sleep medicine this year.
Dr. Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer from 2024.
Make a difference today in a blood cancer patient’s life by supporting The Leukemia & Lymphoma Society https://givenow.lls.org/give/342076/#!/donation/checkout
An MDS HSPC signature generated from the model presents possible targets for treatment in patients with low-risk disease.
Dr. Kasi showcases NEST-1, a look at adverse events and downstaging effects from neoadjuvant bot/bal in pMMR/MSS CRC.
Patient-derived organoids show promise in RCC, enabling personalized therapies and resistance insights.
An analysis of CARTITUDE-4 presented at ASH 2024 showed ciltacabtagene autoleucel has long-term benefits for quality of life in patients with multiple myeloma.
